Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Takehiro, Oikawa"'
Autor:
Masahiro Kurobe, Takahiro Kojima, Kouichi Nishimura, Shuya Kandori, Takashi Kawahara, Takayuki Yoshino, Satoshi Ueno, Yuichi Iizumi, Koji Mitsuzuka, Yoichi Arai, Hiroshi Tsuruta, Tomonori Habuchi, Takashi Kobayashi, Yoshiyuki Matsui, Osamu Ogawa, Mikio Sugimoto, Yoshiyuki Kakehi, Yoshiyuki Nagumo, Masakazu Tsutsumi, Takehiro Oikawa, Koji Kikuchi, Hiroyuki Nishiyama
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0165109 (2016)
Oncogenic FGFR3-TACC3 fusions and FGFR3 mutations are target candidates for small molecule inhibitors in bladder cancer (BC). Because FGFR3 and TACC3 genes are located very closely on chromosome 4p16.3, detection of the fusion by DNA-FISH (fluorescen
Externí odkaz:
https://doaj.org/article/120a0d7aaa6644909b807d8abbb8350a
Autor:
Hiroko Bando, Takehiro Oikawa, Takeshi Saito, Emika Ichioka, Tatsuhiko Ikeda, Hiroko Kiyomatsu, Aya Sawa, Hisato Hara, Akiko Iguchi-Manaka, Mai Okazaki
Publikováno v:
International Cancer Conference Journal. 5:187-191
Nab-paclitaxel (nab-PTX) is a nanoparticle albumin-bound paclitaxel and, as such, is free of solvents like ethanol and polyoxyethylene castor oil. The absence of solvents from this formulation has several practical advantages: it has a shorter infusi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95ba99b8c040a46a9fed7edccd80eb59
https://doi.org/10.1007/s13691-016-0255-9
https://doi.org/10.1007/s13691-016-0255-9
Autor:
Atsushi Ochiai, Kazumi Kamoi, Kyoichi Tomita, Shinichiro Murayama, Koji Okihara, Toru Shimazui, Takehiro Oikawa, Hirotsugu Uemura, Tsuneharu Miki, Tohru Umekawa
Publikováno v:
BJU International. 111:928-933
What's known on the subject? and What does the study add? It is known that a prostate cancer gene 3 (PCA3) urine assay is superior to serum PSA level or PSA-related indices for predicting a positive biopsy result in European and US men. This is the f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bda7535b3e0ccc29efde6b33a23c7ea2
https://doi.org/10.1111/j.1464-410x.2012.11683.x
https://doi.org/10.1111/j.1464-410x.2012.11683.x
Autor:
Hiromu Inai, Mizuki Onozawa, Takehiro Oikawa, Tomokazu Kimura, Satoshi Ando, Jun Miyazaki, Katsunori Uchida, Atsushi Ikeda, Hiroyuki Nishiyama, Koji Kawai
Publikováno v:
International Journal of Urology. 20:716-722
Objective To elucidate the patterns of and risk factors for deterioration of renal function after chemotherapy in metastatic testicular cancer survivors using the estimated glomerular filtration rate. Methods A total of 96 patients who were treated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c86309bc10d0911129cc9bf227d4240
https://doi.org/10.1111/iju.12017
https://doi.org/10.1111/iju.12017
Autor:
Eiichiro Takaoka, Atsushi Ikeda, Koji Kawai, Jun Miyazaki, Takehiro Oikawa, Takahiro Kojima, Satoshi Ando, Takayuki Yoshino, Hiroyuki Nishiyama, Takahiro Suetomi, Hiromu Inai, Tomokazu Kimura
Publikováno v:
Japanese Journal of Clinical Oncology. 42:748-752
OBJECTIVE: Ureteral obstruction is one of the complications of testicular tumor with retroperitoneal lymph node metastasis that requires ureteral stenting for management. We elucidated the clinical courses of ureteral obstructions and changes in rena
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3188fc6b7e6fd738ae52acdc6675f8e
https://doi.org/10.1093/jjco/hys094
https://doi.org/10.1093/jjco/hys094
Autor:
Shiro Hinotsu, Koji Kawakami, Hiroshi Furuse, Hideyuki Akaza, Shota Hamada, Katsuhito Hori, Seiichiro Ozono, Junichi Kawakami, Takehiro Oikawa
Publikováno v:
Supportive Care in Cancer. 20:813-820
The objective of this study was to estimate the cost of antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in daily practice in Japan. This was a retrospective observational study using medical records. Eligible patients were thos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c60b9628feabcba1eceed2fb1dc2d8fa
https://doi.org/10.1007/s00520-011-1155-3
https://doi.org/10.1007/s00520-011-1155-3
Autor:
Takehiro Oikawa, Jun Miyazaki, Hideyoshi Harashima, Ikuya Yano, Akira Joraku, Akihiro Nakaya, Takashi Nakamura, Toru Shimazui, Takahiro Kojima, Koji Kawai, Hideyuki Akaza
Publikováno v:
BJU International. 108:1520-1526
OBJECTIVE • To conduct a preclinical evaluation of the ability of natural killer cells to cytolyze bladder cancer cells that were modified to show enhanced expression of natural-killer group 2, member D (NKG2D) ligands by R8-liposome-bacillus Calme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::977f18365a43d03c920560000c17ab42
https://doi.org/10.1111/j.1464-410x.2010.10056.x
https://doi.org/10.1111/j.1464-410x.2010.10056.x
Autor:
Naoto Miyanaga, Shiro Hinotsu, Koji Kawai, Toru Shimazui, Hideyuki Akaza, Takehiro Oikawa, Ei Ichiro Takaoka, Akira Joraku, Noritoshi Sekido
Publikováno v:
International Journal of Urology. 17:623-628
Objectives: To estimate the risk of intravesical recurrence in patients with primary urothelial cancer of the upper urinary tract. Methods: Ninety patients who underwent radical nephroureterectomy for clinically localized urothelial cancer of the upp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16b4fca9a343224fbabfe56c965d4588
https://doi.org/10.1111/j.1442-2042.2010.02539.x
https://doi.org/10.1111/j.1442-2042.2010.02539.x
Autor:
Akira Joraku, Noritoshi Sekido, Naoto Miyanaga, Hideyuki Akaza, Shiro Hinotsu, Takahiro Suetomi, Koji Kawai, Toru Shimazui, Takehiro Oikawa
Publikováno v:
The Journal of Sexual Medicine. 5:1443-1450
Introduction Several recent studies suggested that the prevalence of erectile dysfunction (ED) was higher in men with metabolic syndrome (MS). Aim We analyzed the impact of MS on the responsiveness to sildenafil. Methods A total of 133 ED patients we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::094fb6ad84b2654b5de24f77d44d6d5b
https://doi.org/10.1111/j.1743-6109.2007.00747.x
https://doi.org/10.1111/j.1743-6109.2007.00747.x
Autor:
Naoto Miyanaga, Toru Shimazui, Akira Joraku, Koji Kawai, Shiro Hinotsu, Takehiro Oikawa, Takahiro Kojima, Hideyuki Akaza, Noritoshi Sekido
Publikováno v:
Japanese Journal of Clinical Oncology. 37:603-608
Background: We previously reported that weekly treatment with docetaxel alone is useful for and well tolerated by patients with hormone-refractory prostate cancer (HRPC). Here, we compare it with the regimen of docetaxel once every 3 weeks (q3w) plus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d6ce391e701b707c8da6ca78bd7d29b
https://doi.org/10.1093/jjco/hym071
https://doi.org/10.1093/jjco/hym071